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Abstract: 1 
Persistent organic pollutants (POPs) are toxic substances, highly resistant to environmental 2 
degradation, which can bio-accumulate and have long-range atmospheric transport potential. Most 3 
studies focus on single compound effects, however as humans are exposed to several POPs 4 
simultaneously, investigating exposure effects of real life POP mixtures on human health is 5 
necessary. A defined mixture of POPs was used, where the compound concentration reflected its 6 
contribution to the levels seen in Scandinavian human serum (total mix). Several sub mixtures 7 
representing different classes of POPs were also constructed. The perfluorinated (PFC) mixture 8 
contained six perfluorinated compounds, brominated (Br) mixture contained seven brominated 9 
compounds, chlorinated (Cl) mixture contained polychlorinated biphenyls and also p,p’-10 
dichlorodiphenyldichloroethylene, hexachlorobenzene, three chlordanes, three 11 
hexachlorocyclohexanes and dieldrin. Human hepatocarcinoma (HepG2) cells were used for 2h and 12 
48h exposures to the seven mixtures and analysis on a CellInsightTM NXT High Content Screening 13 
platform. Multiple cytotoxic endpoints were investigated: cell number, nuclear intensity and area, 14 
mitochondrial mass and membrane potential (MMP) and reactive oxygen species (ROS). Both the Br 15 
and Cl mixtures induced ROS production but did not lead to apoptosis. The PFC mixture induced ROS 16 
production and likely induced cell apoptosis accompanied by the dissipation of MMP. Synergistic 17 
effects were evident for ROS induction when cells were exposed to the PFC+Br mixture in 18 
comparison to the effects of the individual mixtures. No significant effects were detected in the 19 
Br+Cl, PFC+Cl or total mixtures, which contain the same concentrations of chlorinated compounds as 20 
the Cl mixture plus additional compounds; highlighting the need for further exploration of POP 21 
mixtures in risk assessment. 22 
Keywords: 23 
Persistent organic pollutants; mixtures; cytotoxicity; high content analysis. 24 
 25 
 26 
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1. Introduction 27 
Persistent organic pollutants (POPs) are toxic substances, highly resistant to environmental 28 
degradation, which can bio-accumulate and have long-range atmospheric transport potential (UNEP 29 
2001) therefore potential effects on human health need to be investigated. POPs such as 30 
polychlorinated biphenyls (PCBs) and polybrominated diphenyl ethers (PBDEs) are well established 31 
pollutants (de Wit et al. 2010; Letcher et al. 2010). Due to their lipophilic nature and resistance to 32 
degradation, POPs accumulate in living organisms and biomagnify in food chains (de Wit et al. 2004), 33 
resulting in high levels in tissues of top predators and humans (Bytingsvik et al. 2012; Muir and de 34 
Wit 2010). POPs are of global concern and have been detected in human adipose tissue, serum and 35 
breast milk samples collected in Asia, Europe, North America and the Arctic (Bi et al. 2006; Pereg et 36 
al. 2003; Sjödin et al. 1999; Sjödin et al. 2008). 37 
 Exposure to POPs has been associated with adverse effects in animals including 38 
neurobehavioural development disruption (Johansson et al. 2008), impaired memory and learning 39 
(Kuriyama et al. 2005; Viberg et al. 2003) and disruption of neural proteins involved in synapse 40 
formation and growth (Johansson et al. 2009). Other effects include liver hypertrophy, alteration in 41 
liver enzymes, hepatomegaly and tumours (Butenhoff et al. 2004), developmental problems in 42 
rodent offspring exposed in utero (Lindstrom et al. 2011) and evidence of endocrine disruption 43 
(White et al. 2011).  44 
Evidence of endocrine disrupting potential, as well as other harmful effects from POPs has 45 
been reported in humans. Importantly, studies have shown that POPs can cross the placenta and 46 
accumulate in the foetus (Beesoon et al. 2011; Inoue et al. 2004; Ode et al. 2013). Prenatal exposure 47 
to POPs has been associated with effects on birth weight, duration of pregnancy, visual memory 48 
(Van Oostdam et al. 2003), impaired immune function (Heilmann et al. 2006) and increased risk of 49 
middle ear infections (Dewailly et al. 2000). Furthermore babies are exposed to POPs through breast 50 
feeding (Llorca et al. 2010; Waliszewski et al. 2009). This implies that they are exposed before birth 51 
and during the early sensitive developmental stages of their lives to POPs. The endocrine disrupting 52 
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potential of POPs in humans has also been highlighted (Bonde et al. 2008; Longnecker et al. 2007; 53 
Lyche et al. 2011). Exposure to POPs has been associated with decreased fertility (Harley et al. 2010) 54 
and infertility in women (Fei et al. 2009), altered sex hormone and thyroid hormone homeostasis 55 
(Ellis-Hutchings et al. 2006; Hallgren and Darnerud 2002; Persky et al. 2001), dermatological effects 56 
such as rashes and acne (Ritter et al. 1995) and type 2 diabetes (Grandjean et al. 2011).  57 
Animals and humans are exposed to mixtures of POPs. Therefore investigating the effect of 58 
one POP in isolation is not representative of real life exposure. Instead it is more important to look 59 
at how mixtures of POPs work in combination to affect health. Only single compound exposure is 60 
currently considered by risk assessment authorities (Kortenkamp 2007), potentially leading to an 61 
ignorance of additive, synergistic or antagonistic effects and the misinterpretation of the risk of POP 62 
exposure as complex mixtures. The toxicological determination of complex mixtures has been 63 
highlighted as one of the most important challenges for modern toxicology (Fent 2003; Kortenkamp 64 
2007; Vaiseman 2011). In the present study, the effect of complex mixtures on several cellular 65 
responses, in an in vitro liver model using human hepatocarcinoma (HepG2) cells, was studied. High 66 
Content Analysis (HCA) was used in conjunction with the conventional 3-(4,5-dimethylthiazol-2-yl)-67 
2,5 diphenyltetrazolium bromide (MTT) assay. HCA is a novel, high-throughput, quantitative 68 
fluorescence technique that can examine chemical induced toxicity at sub-cellular microscopic 69 
resolution. It amalgamates fluorescence microscopy with automated cell analysis software allowing 70 
the simultaneous assessment of multiple morphological and functional cell parameters (Abraham et 71 
al. 2004; Giuliano et al. 2003). Using toxicity assays, HCA can detect subtle pre-lethal changes in cell 72 
health rather than obvious lethal cytotoxicity detected by the conventional MTT assay (O’Brien 73 
2008; O’Brien and Haskins 2007). The liver is the main metabolic organ for degrading xenobiotics. As 74 
such the liver often shows the earliest signs of injury, and therefore it is useful to model the effects 75 
of POP mixtures on a liver cell line. Furthermore, POPs such as PCBs tend to accumulate in the liver 76 
(Bachour et al. 1998). It may be assumed that primary human hepatocytes would be most 77 
appropriate for use in predicting human toxicity however these cells dedifferentiate over the time of 78 
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the assay. Furthermore as they are non-proliferative critical toxicity parameters would be lost. 79 
HepG2 are considered to be one of the best single-cell models for predicting human toxicity 80 
potential (O’Brien 2014). They are also highly sensitive in the recognition of effects on mitochondrial 81 
DNA and mitochondrial function (Pinti et al. 2003). This sensitivity coupled with the ability to 82 
incorporate multiple parameters suggests that HCA, using HepG2 cells, is an appropriate candidate 83 
for investigating POP mixtures.  84 
 Assay parameters which can be optimised and measured using HCA include: cell number 85 
(CN), nuclear area (NA), nuclear intensity (NI), mitochondrial membrane potential (MMP), 86 
mitochondrial mass (MM) and reactive oxygen species (ROS). These markers cover cellular metabolic 87 
functions and are markers of cell health (O’Brien 2008; O’Brien and Haskins 2007; Walsh et al. 2011). 88 
O’Brien et al. (2006) reported that the most sensitive HCA toxicity parameters in HepG2 cells are cell 89 
proliferation, mitochondrial health and NA. Enhanced biogenesis of mitochondria can increase MM 90 
due to increased mitochondrial respiration and this often corresponds with reduced MMP (O’Brien 91 
and Haskins 2007). Mitochondria serve as a site of regulation of programmed cell death (apoptosis). 92 
Apoptosis can occur when cells are damaged by disease or noxious agents (Norbury and Hickson 93 
2001). A hallmark of early apoptosis is cell shrinkage and pyknosis which is the condensation of 94 
chromatin in the nucleus (Kerr et al. 1972). Necrosis is an alternative to apoptotic cell death by 95 
which the cell passively follows an energy-independent mode of death. The cells will swell in 96 
contrast to apoptotic cells which shrink. Although there are distinct differences in the mechanisms of 97 
apoptosis and necrosis, there is overlap between the two processes described as the “apoptosis-98 
necrosis continuum” (Zeiss 2003). O’Brien et al. (2006) highlighted the need to incorporate an 99 
oxidative stress biomarker in HCA screening. Excessive ROS can induce oxidative damage in cells and 100 
impair cellular functions (Aims et al. 1993; Halliwell and Gutteridge 1999). Cellular antioxidants 101 
protect against the damaging effects of ROS. However, in moderate concentrations, ROS are 102 
necessary for a number of protective reactions (Halliwell and Gutteridge 1999).  103 
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This study aimed to improve the understanding of POP mixture induced toxicity by using a 104 
multi-parameter HCA cytotoxicity assay for the study of exposure of HepG2 cells to POP mixtures. It 105 
is important to assess POPs in mixtures as it reflects real life exposure and it may be possible to 106 
highlight the mechanisms by which POP mixtures induce toxicity, particularly pre-lethal toxicity. 107 
Furthermore comparison of the conventional MTT cytotoxicity assay coupled with the HCA assay will 108 
help determine if HCA can be used to better measure POP mixture toxicity. While individual POPs 109 
have been the focus of many studies, mixtures of POPs have not been extensively examined. 110 
Investigations of POP mixtures are crucial as the evidence of their health effects on humans and 111 
animals is irrefutable. 112 
 113 
2. Materials and Methods 114 
 115 
2.1. Chemicals 116 
All PBDEs, PCBs and other organochlorines were originally purchased from Chiron As (Trondheim, 117 
Norway). All perfluorinated compounds (PFCs) were obtained from Sigma-Aldrich (St. Louis, MO, 118 
USA) except perfluorohexanesulfonic acid (PFHxS) which was from Santa Cruz (Dallas, US). 119 
Hexabromocyclododecane (HBCD), phosphate buffered saline (PBS), dimethyl sulfoxide (DMSO), 120 
thiazolyl blue tetrazolium bromide (MTT) and menadione were obtained from Sigma–Aldrich 121 
(Dorset, UK). CellROX Deep Red reagent and other cell culture reagents were supplied by Life 122 
Technologies (Paisley, UK) unless otherwise stated. Mitochondrial membrane potential dye (MMPD) 123 
and Hoechst nuclear stain 33342 were purchased from Perbio (Northumberland, England). All other 124 
reagents were standard laboratory grade.  125 
 126 
2.2. Mixtures 127 
Mixtures of the test POPs were designed and premade by the Norwegian University of Life Sciences, 128 
Oslo. Seven mixtures were used in the cell assays (Table 1): (1) total mixture, containing all the test 129 
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compounds, (2) perfluorinated mixture (PFC), (3) brominated mixture (Br), (4) chlorinated mixture 130 
(Cl), (5) perfluorinated and brominated mixture (PFC + Br), (6) perfluorinated and chlorinated 131 
mixture (PFC + Cl) and (7) brominated and chlorinated mixture (Br + Cl). The chemicals included in 132 
the mixtures and their respective concentrations in the stock solution are shown in Table 1 133 
(Berntsen et al. 2016). The POP mixtures used in this study were based on concentrations of relevant 134 
POPs measured in human blood, according to recent studies of the Scandinavian population (Haug et 135 
al. 2010; Knutsen et al. 2008; Polder et al. 2008; Polder et al. 2009; Van Oostdam et al. 2004) as 136 
described in Berntsen et al. (2016). The compounds were mixed in concentration ratios relevant to 137 
human exposure. The stocks of the total mixture, Cl mixture and the Cl sub-mixtures were ten times 138 
more diluted compared to the PFC and the Br mixtures and the combined PFC + Br sub-mixture. 139 
 140 
2.3. Cell Culture and Treatment 141 
HepG2 cells were routinely cultured in a humidified atmosphere of 5% CO2 at 37 °C. Cells were 142 
grown in 75 cm2 flasks in MEM media supplemented with 10% foetal bovine serum, 2mM L-143 
Glutamine, 1% penicillin-streptomycin and 1mM sodium pyruvate. TrypLETM Express trypsin was 144 
used to disperse the cells from the flasks, while cell counting and viability checks prior to seeding 145 
plates were achieved by trypan blue staining and using a Countess® automated cell counter. 146 
 Cells were seeded into collagen bio-coat BD Falcon 96 well flat bottomed microtitre plates 147 
(BD Biosciences, Bedford, MA, US) at a density of 6 x 104 cells/ml and allowed to attach for 24 h. The 148 
cells were then exposed to 1/1000, 1/2000, 1/10000 and 1/20000 dilutions of the original stocks, 149 
which corresponded to 10000, 5000, 1000 and 500 times the levels in serum for PFC, Br and PFC + Br 150 
mixtures. For the remaining mixtures (total, Cl, PFC + Cl and Br + Cl) the exposures corresponded to 151 
1000, 500, 100 and 50 times the levels in serum. The dilutions were performed in the same media as 152 
stated above. Incubation periods were: 2 h or 48 h. A solvent control of 0.2% (v:v) DMSO in media 153 
was also included. The duration of exposure for the study was chosen to cover early cellular 154 
events/effects and the eventual consequences thereof after 48 hr exposure. 155 
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 156 
2.4. Analysis of Multiple Cellular Parameters by High Content Analysis (HCA) 157 
Cellomics® High Content Screening reagent series multi-parameter cytotoxicity dyes were used by 158 
following manufacturer’s instructions. MMPD was prepared by adding 117 µl of DMSO to make a 1 159 
mM stock solution. The live cell stain was prepared by adding 6.75 µl of the MMPD and 27 µl of 160 
CellROX reagent (resulting in a final cell exposure concentration of 5 µM) in 1500 µl of media for 161 
each assay plate. Following incubation, the plate was protected from light and 25 µl of live cell stain 162 
was added to each well for 30 min at 37 °C. Cells were fixed with 10% formalin solution for 20 min at 163 
room temperature (RT) and washed with PBS. Hoechst 33342 dye (at a final concentration of 1.6 164 
µM) was added to each well and incubated for 10 min at RT, after which cells were washed with PBS. 165 
The wells were then filled with 200 µl PBS, sealed with a plate sealer and evaluated on CellInsightTM 166 
NXT High Content Screening (HCS) platform (Thermo Fisher Scientific, UK). This instrument analyses 167 
epifluorescence of individual cell events using an automated micro-plate reader analyser interfaced 168 
with a PC (Dell precision 136 T5600 workstation).  169 
 Hoechst dye was used to measure parameters reflecting nuclear morphology: CN, NI and 170 
NA. MMPD was used to evaluate parameters of mitochondrial function: MMP and MM. CellROX® 171 
Deep Red Reagent was used to measure ROS. Data was captured for each plate at 10x objective 172 
magnification in the selected excitation and emission wavelengths for Hoechst dye (Ex/Em 350/461 173 
nm), MMPD (Ex/Em 554/576 nm) and CellROX reagent (Ex/Em 640/665 nm). Nine field view images 174 
were acquired in each well to examine each parameter. 175 
 176 
2.5. MTT Assay 177 
As well as visual inspection of the HepG2 cells under the microscope to evaluate cell morphology 178 
and attachment, the MTT cell viability assay was performed to act as a comparison to the HCA 179 
cytotoxicity assay.  180 
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The cells were exposed exactly as in Section 2.3 after which the percentage of viable cells 181 
was determined. In the MTT assay viable cells convert the soluble yellow MTT to insoluble purple 182 
formazan by the action of mitochondrial succinate dehydrogenase. The cells were washed once with 183 
PBS. MTT solution (50 µl of 2 mg/ml stock in PBS diluted 1:2.5 in assay media) was added to each 184 
well and the cells incubated for 3 h. The supernatant was removed and 200 µl of DMSO was added 185 
to dissolve the formazan crystals. Subsequently, the plate was incubated at 37 °C with agitation for 186 
10 min. Absorbance was measured at 570 nm with a reference filter at 630 nm using a microtitre 187 
plate reader (TECAN, Switzerland). Viability was calculated as the percentage absorbance of the 188 
sample compared to the absorbance of the solvent control. 189 
 190 
2.6. Statistical Analysis 191 
Exposures were carried out in triplicate wells and three independent exposures performed. The 192 
coefficient of variation (CV) was calculated for the three exposures; all parameters were below 15% 193 
except for ROS production which was below 25%. Data was analysed using Microsoft Excel and 194 
Graphpad PRISM software, version 5.01 (San Diego, CA). All values shown are expressed as mean ± 195 
standard error of the mean (SEM) of the independent exposures. Data is expressed as a percentage 196 
of untreated (solvent) control for each parameter. Data was analysed by one-way ANOVA followed 197 
by Dunnett’s procedure for multiple comparisons; the mean concentrations were tested for 198 
significant difference at the 95% confidence level. A p value of ≤ 0.05 was considered as significant, p 199 
≤ 0.05 (*) ≤ 0.01 (**) ≤ 0.001 (***). 200 
 201 
2.7. Comparison between expected and measured results 202 
The expected values were calculated by addition of the mean value after exposure to one mixture 203 
(e.g. PFC mixture) alone with the mean value obtained after exposure to the second mixture (e.g. Br 204 
mixture) (Weber et al. 2005). For example: 205 
Mean (expected for PFC + Br) = mean (PFC) + mean (Br) – 100% 206 
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Furthermore to calculate expected SEM, the following equation was used: 207 
SEM (expected for PFC + Br) = [(SEM for PFC)2 + (SEM for Br)2]1/2 208 
An unpaired t-test was used to calculate the significance of difference in the expected and measured 209 
values, with p ≤ 0.05 being considered statistically significant. Interpretation of the results were as 210 
follows: 211 
 Additive effects: measured values were not significantly higher or lower than expected 212 
values. 213 
 Synergistic effects: measured values were significantly below expected values for 214 
parameters CN, NI and MMP and significantly above for parameters NA, MM and ROS. 215 
 Antagonistic effects: measured values were significantly above expected values for 216 
parameters CN, NI and MMP and significantly below for parameters NA, MM and ROS. 217 
3. Results 218 
 219 
HCA methodology multiple parameters (CN, NA, NI, MM, MMP and ROS) representative for different 220 
cellular events and functionality were measuring using HepG2 cells exposed to defined POP 221 
mixtures. In parallel, cytotoxicity was measured using a standard MTT assay procedure. 222 
 223 
3.1. Cytotoxicity as measured by MTT Assay  224 
 225 
Exposure (2 h) to the highest concentrations of the PFC mixture (equivalent to 5000 and 10000 times 226 
serum levels) reduced cell viability to 82.4% and 55.5% respectively (p ≤ 0.05, p ≤ 0.001, Figure 1). 227 
Cell viability was also reduced after 48 h exposure however it was more pronounced 3.1 % and 1.8% 228 
cell viability respectively (p ≤ 0.001, Figure 1). A reduction in cell viability was also evident after 2 h 229 
exposure with the highest concentration of PFC + Br mixture, 66.9% cell viability (p ≤ 0.001, Figure 230 
1). Reductions in cell viability were evident after 48 h exposure for the two highest concentrations of 231 
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this mixture, 1.2% and 0.9% respectively (p ≤ 0.001, Figure 1). Total, Br, Cl, PFC + Cl and Br + Cl 232 
mixtures had no significant cytotoxic effects in the MTT assay (data is not shown for these mixtures 233 
as no significant effects were found; Br is included only to enable comparisons to PFC with and 234 
without Br). 235 
 236 
3.2 Cytotoxicity as measured by CN, NA and NI  237 
 238 
Exposure (2 h) to the highest concentration of the PFC mixture reduced CN to 40.9% (p ≤ 0.01; Figure 239 
2A). CN was also found to be significantly decreased after 48 h exposure to this mixture at the two 240 
highest concentrations, 1.7% and 0.8% cell viability respectively (p ≤ 0.001; Figure 2A). Similarly, 48 h 241 
exposure to the PFC + Br mixture was found to lower CN at the two highest concentrations, 1.1% 242 
and 1.3% cell viability respectively (p ≤ 0.001; Figure 2A).  243 
 244 
NI was found to be significantly increased after 48 h exposure to the PFC mixture at the two highest 245 
concentrations, 166.3% and 156.9% nuclear intensity respectively (p ≤ 0.01, p ≤ 0.05; Figure 2B). The 246 
PFC + Br mixture at the two highest concentrations was also found to increase nuclear intensity, 247 
153.7% and 142.0% respectively (p ≤ 0.001, p ≤ 0.01; Figure 2B). Even during the 2 h exposure the 248 
highest concentration of the PFC + Br mixture was found to significantly increase nuclear intensity to 249 
127.3% (p ≤ 0.01; Figure 2B).  250 
 251 
NA was found to be significantly increased after 48 h exposure to the PFC mixture (equivalent to 252 
5000 times serum levels), 187.2% nuclear area (p ≤ 0.001, Figure 2C). Exposure (2 h) to the PFC + Br 253 
mixture at the highest concentration decreased nuclear area to 68.5% (p ≤ 0.05, Figure 2C). 254 
However, after 48 h exposure, the two highest concentrations were found to increase nuclear area, 255 
164.9% and 196.6% respectively (p ≤ 0.001, Figure 2C). 256 
 257 
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The other mixtures (total, Br, Cl, PFC + Cl and Br + Cl) caused no significant changes to CN, NA or NA 258 
(data is not shown for these mixtures as no significant effects were found; Br is included only to 259 
enable comparisons to PFC with and without Br). 260 
 261 
3.3 Cytotoxicity as measured by MM and MMP 262 
 263 
All concentrations of the Cl mixture (100, 500 and 1000 times serum levels), apart from the most 264 
dilute (50 times serum levels), were found to significantly increase MM to 106.6%, 108.5% and 265 
109.7% respectively (p ≤ 0.05, p ≤ 0.01 and p ≤ 0.001, Figure 3) after 48 h exposure. Although the 266 
results are statistically significant, the biological significance is likely to be minor as these inductions 267 
are very low.  268 
 269 
The only mixture to show significant changes in MM after 2 h exposure was the Br mixture (at 1000 270 
times serum levels), increasing to 109.4% (p ≤ 0.01, Figure 4A). However MM increased significantly 271 
after 48 h exposure to the PFC mixture at the two highest concentrations, to 160.9% and 172.5% 272 
mitochondrial mass (p ≤ 0.01, Figure 4A). The PFC + Br mixture at the highest concentration was also 273 
found to increase MM to 206.5% (p ≤ 0.05, Figure 4A).  274 
 275 
MMP decreased significantly after 2 h and 48 h exposure to the PFC mixture at the two highest 276 
concentrations to 64.1% and 46.6% (p ≤ 0.001) and 22.3% and 11.7% respectively (p ≤ 0.001, Figure 277 
4B). Exposure (2 h) to the PFC + Br mixture at the highest concentration was found to decrease MMP 278 
to 66.7% (p ≤ 0.05, Figure 4B). After 48 h exposure the two highest concentrations were also found 279 
to decrease MMP to 40.0% and 25.5% respectively (p ≤ 0.001, Figure 4B). 280 
 281 
The total, PFC + Cl and Br + Cl mixtures caused no significant changes to MM or MMP (MM shown in 282 
Figure 3, MMP data not shown). 283 
 284 
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3.4. Oxidative Stress 285 
 286 
Increased ROS production was detected after 2 h exposure to the highest concentration of the PFC 287 
mixture, Br mixture, Cl mixture and PFC + Br mixture (190.1% p ≤ 0.001, 149.5% p ≤ 0.05, 137.3% p ≤ 288 
0.05 and 348.4% p ≤ 0.001, Figure 5). The increase in red fluorescence after 2 h exposure to the 289 
highest concentration of PFC + Br mixture can be seen in Figure 6. The second highest concentration 290 
(500 times serum levels) of the Cl mixture also caused significant increase in ROS 135.2% (p ≤ 0.05, 291 
Figure 5). 292 
 293 
Increased ROS production was detected after 48 h exposure to the highest concentration of PFC 294 
mixture, Br mixture, Cl mixture and PFC + Br mixture (466.7% p ≤ 0.001, 178.1% p ≤ 0.01, 141.1% p ≤ 295 
0.01 and 525.3% p ≤ 0.001 respectively, Figure 5).  296 
 297 
The total, PFC + Cl and Br + Cl mixtures caused no significant changes in ROS production (data not 298 
shown). 299 
 300 
A summary of the results are shown in table 2 (2 h exposure) and table 3 (48 h exposure). 301 
 302 
 303 
3.5. Assessing the interactive effects of the PFC + Br mixture 304 
The addition of the Br mixture to the PFC mixture produced some interesting results. After 2 h 305 
incubation, no significant change in CN was observed for the highest concentration of PFC + Br 306 
mixture; keeping in mind that the PFC mixture alone at this concentration lowered CN to 40.9%. 307 
However this observed value was not deemed statistically significant from the expected value p > 308 
0.05. In contrast a synergistic effect was evident for this concentration for MM with a 28% (p ≤ 0.05) 309 
difference between expected and observed values. Furthermore for ROS production (2 h) exposure 310 
to the PFC + Br mixture (at 5000 times serum levels) was deemed to reflect synergistic effects 311 
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between the individual mixtures as the observed ROS value (188%) was significantly higher than the 312 
expected value (113%, p ≤ 0.05). However the ROS production induced by the highest concentration 313 
(348%, 10000 times serum levels) was not deemed to be statistically significantly different to the 314 
expected value (239%) and is therefore considered additive. Exposure for 48 h to the PFC + Br 315 
mixture again resulted in higher ROS production than expected after exposure to each of the 316 
mixtures independently. The values observed for 1000 and 5000 times serum levels were deemed to 317 
be synergistic (p ≤ 0.05) while 500 and 10000 times serum levels were additive. 318 
 319 
4. Discussion 320 
Compared to single end-point cytotoxicity assays, HCA has the scope to investigate different 321 
mechanistic endpoints for cellular health and death simultaneously and therefore might better 322 
demonstrate the risk of human exposure to complex mixtures of environmental contaminants. 323 
Cell population count or CN, followed by NA, are the most affected by cytotoxic drugs 324 
(O’Brien 2014). There was a high result concordance between using the MTT assay (Figure 1) and CN 325 
as a measure of cell viability (Figure 2A). For 48 h exposure, the same mixtures and concentrations 326 
(PFC and PFC + Br) were highlighted as statistically significant by both assays. However for 2 h 327 
exposure, the HCA parameter CN highlighted fewer mixtures and concentrations as toxic than the 328 
MTT assay. Since the MTT assay determines mitochondrial activity it is crucial to include the HCA 329 
mitochondrial parameters as a comparison. When these are considered the HCA showed MM 330 
changes in two mixtures, Cl (Figure 3) and Br mixtures (Figure 4A), that the MTT assay failed to 331 
highlight. Therefore combined HCA endpoints were found to be more sensitive at detecting 332 
cytotoxicity and revealed toxic effects where the conventional MTT endpoint showed none. 333 
As far as the authors of this paper are aware, the combinations of compounds used in this 334 
study are unique to this collaborative group. Cellular effects of single PFCs on HepG2 cells have 335 
previously been reported for perfluorooctanoic acid (PFOA), ranging from cell cycle perturbations 336 
(starting at 50 µM), apoptosis (200–450 µM), to necrosis (400-500 µM) (Shabalina et al. 1999). 337 
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Florentin et al. (2011) observed a reduction in viability after exposure to PFOA (200 µM) or 338 
perfluorooctanesulfonic acid (PFOS) (300 µM) for 24 h. Hu and Hu (2009) reported a similar 339 
concentration-dependent decrease in cell viability for PFOA and PFOS, and pointed to additive 340 
effects in combined exposures. These concentration ranges correspond to the two highest 341 
concentrations of the PFC mixtures used in the present study, containing 54/109 µM and 273/546 342 
µM of PFOA and PFOS respectively, where a significant reduction in cell viability (measured by MTT 343 
and CN) was observed after 48 h. However, whereas Florentin et al. (2011) reported no cytotoxicity 344 
after 1 h, a significant decrease in viability (measured by CN) was evident after 2 h for the two 345 
highest concentrations of the PFC mixture in our study. This may indicate that the CN parameter in 346 
the HCA is more sensitive in detecting early onset of cytotoxic alterations. 347 
As shown by Shabalina et al. (1999) exposure of HepG2 cells to single PFCs can result in both 348 
apoptosis and necrosis, depending on concentration and exposure time, suggesting on overlap 349 
between the two processes described as the “apoptosis-necrosis continuum” (Zeiss 2003). Indeed, in 350 
the present study changes in specific HCA endpoints were indicative of both modes of cell death.  351 
One apoptosis-induction pathway is mediated by early mitochondrial alterations, with the opening 352 
of the mitochondrial permeability transition (MPT) pore resulting in the release of mitochondrial 353 
proteins which initiate and execute the process of cell destruction. This mitochondrial dysfunction is 354 
reflected by a decrease in MMP, generally considered an early marker for this pathway (Bernardi et 355 
al. 1992; Gottlieb et al. 2003). A decrease in MMP may be expected to accompany an increase in 356 
MM as disruption of MMP/MPT pore opening induces mitochondrial swelling (Minamikawa et al. 357 
1999). A reduction in MMP was evident after 2 h incubation with the PFC mixture (64.1% at 5000, 358 
and 46.6% at 10000 times serum levels; Figure 4B), after 48 h exposure the MMP decreased further 359 
while the MM had increased. Nuclear shrinkage is a hallmark of apoptosis while the swelling of 360 
nuclei is linked to compound-induced necrosis. In contrast to the changes indicative of apoptosis 361 
observed for the PFC mixture (5000 times serum levels) at 2 and 48 h, the findings at 48 h of 362 
significantly increased NA would be indicative of nuclear swelling and necrosis (Figure 2C). NA was 363 
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not significantly changed for the higher concentration of the PFC mixture, however CN was found to 364 
be reduced significantly, suggesting that any apoptotic or necrotic cells had been lost at this point. 365 
ROS are a known mediator of apoptosis, and the opening of the MPT pore can be initiated 366 
and augmented by elevated ROS (Atlante et al. 2000). In the HCA assay ROS production was 367 
measured using the cell-permeable CellROX® Deep Red Reagent, which locates to the cytoplasm, 368 
and exhibits a strong fluorescent signal upon oxidation. The induction of ROS was observed after 2h 369 
and 48 h exposure to the highest concentration of the PFC mixture (Figure 5). Similar studies with 370 
PFOA and PFOS (Hu and Hu 2009; Panaretakis et al. 2001) also reported induction of ROS. It is 371 
reasonable to deduce that the PFC mixture containing PFOA and PFOS potentially exerts its toxic 372 
effects on HepG2 cells through ROS-mediated cell apoptosis. It is possible that the loss of MMP and 373 
the increase in ROS are not two separate ways of inducing apoptosis but rather that they are linked. 374 
Damaged mitochondria are a major source of ROS. Excessive ROS may cause the mitochondria 375 
further damage, reducing MMP and consequently inducing apoptosis (Ricci et al. 2003; Simizu et al. 376 
1998). This further supports the observation that the PFC mixture can induce apoptosis in HepG2 377 
cells. However, further investigation is required to fully elucidate the mechanism. 378 
No decrease in cell viability, measured using MTT or CN, was seen at any concentration or 379 
exposure time after exposure to the Cl mixture. However, MM was significantly increased after 48 h 380 
exposure to the Cl mixture at all concentrations tested above 50 times serum levels (Figure 3). 381 
Exposure to the Cl mixture also increased ROS production, after both 2 h exposure (500 and 1000 382 
times serum levels), as well as after 48 h exposure (1000 times serum levels; Figure 5). Exposure to 383 
individual PCBs has been shown to lead to uncontrolled ROS accumulation and cellular oxidative 384 
stress (Liu et al. 2012). Mitochondria can also swell in a fully reversible manner, without inducing cell 385 
death (Minamikawa et al. 1999; Petronilli et al. 1994). Therefore the level of ROS produced by the 386 
HepG2 cells after exposure to the Cl mixture may have been sufficient to open the MPT pore and 387 
cause mitochondrial swelling but not enough to irreversibly damage the cells. This further illustrates 388 
the ability of the HCA assay to pick up early signs and/or reversible signs of cellular stress. 389 
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Incubation of HepG2 cells with the Br mixture for 2 h and 48 h did not produce any 390 
significant changes in the MTT assay or CN, NI, NA, MMP parameters in the HCA. Studies have 391 
investigated the effects of single PBDEs on different cell types. BDE-47 and BDE-99 (0.1–10 μM) 392 
proved non- cytotoxic for proliferating or differentiating human neural progenitor cells over a period 393 
of 2 weeks (Schreiber et al. 2010). However, cytotoxicity due to the induction of apoptosis has been 394 
reported for single PBDEs in rat cerebellar granule cells (Reistad et al. 2006), human astrocytoma 395 
cells (Madia et al. 2004), hippocampal neurons, human neuroblastoma cells, human foetal liver 396 
haematopoietic cells (He et al. 2008, He et al. 2009; Shao et al. 2008) and HepG2 cells (Hu et al. 397 
2007). These studies tested much higher levels of the individual PBDEs than those present in the Br 398 
mixture. For example, Hu et al. (2007) tested 1-100 µM of BDE-209, with cytotoxicity only being 399 
evident at concentrations > 10 µM. In comparison, at the highest concentration of the Br mixture 400 
tested, BDE-209 is present at only 0.11 µM. Giordano et al. (2008) demonstrated that a technical 401 
mixture of PBDEs induces oxidative stress in rat cerebellar granule neurons. Time and concentration-402 
dependent induction of ROS in HepG2 cells by BDE-209 has been observed with effects only 403 
appearing after exposure to concentrations >10 μM (Hu et al. 2007). They concluded that BDE-209 404 
inhibited the proliferation of Hep G2 cells by inducing apoptosis through ROS generation. In the 405 
present study increased ROS were detected after 2 h and 48 h exposure to the highest concentration 406 
of the Br mixture (Figure 5). As the concentrations of PBDEs in the Br mixture used here are much 407 
lower in comparison to other studies, it may be possible that even at low concentrations PBDEs 408 
induce ROS generation but that it does not lead to apoptosis. 409 
The addition of the Br mixture to the PFC mixture produced some interesting results. As the 410 
concentrations of PFCs present in the combined mixture is the same as in the PFC mixture alone, it 411 
might be expected that toxicity would stay the same or increase. Further effects were observed in 412 
HepG2 cells after 2 h exposure to the highest concentration of the PFC + Br mixture (10000 times 413 
serum levels) for NA and NI (decreased and increased respectively); there were no significant effects 414 
at this concentration for either the PFC or Br mixture alone (Figure 2). These changes in nuclear 415 
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parameters are indicative of apoptosis. Furthermore, significant synergistic effects (p ≤ 0.05) were 416 
evident for the PFC + Br for MM (at 10000 times serum levels) and ROS (5000 times serum levels). In 417 
addition, 48 h exposure to this combined mixture resulted in synergistic effects observed for ROS 418 
production at two concentrations (1000 and 5000 times serum levels), while additive effects 419 
occurred at 500 and 10000 times serum levels. As PBDEs and PFCs are known to induce oxidative 420 
stress the synergy observed for MM and ROS is plausible. 421 
Understanding the complexity of POP mixtures is crucial to the assessment of risks to human 422 
health. It is not a simple scenario of the more POPs present, the more risk to health; the issue is 423 
more complex. In addition to what has previously been discussed for ROS production, this is 424 
highlighted by comparing all mixtures at 1000 and 500 times the levels found in human serum. MM 425 
was increased after 48 h exposure to the Cl mixture. However no such increase was evident after 48 426 
h exposure to the PFC + Cl mixture. Similarly 2 h exposure to the Br mixture alone, at 1000 times 427 
serum levels, caused MM to increase. However 2 h exposure to the Br + Cl mixture had no significant 428 
effects. Furthermore the total mixture, which contains all of the individual POPs, had no cytotoxic 429 
effects at any concentration. This highlights the complexity of investigating mixtures. It is also 430 
understandable that determining the toxicity of complex mixtures is considered one of the most 431 
important challenges for modern toxicology (Fent 2003; Kortenkamp 2007; Vaiseman 2011). All of 432 
the studies discussed thus far have used conventional methods to assess cell health, while the 433 
present study used HCA as a comparable but novel approach for investigating the toxicity of POP 434 
mixtures via multiple and pre-lethal toxicity markers.  435 
Due to the requirement for a proliferating cell model in predictive cytotoxicity studies, the 436 
suitability of the HepG2 cell line in this role is supported by other studies. However as the results 437 
from HCA have now been deemed as comparable to other studies, a cell line with metabolic 438 
competence more akin to the in vivo state would likely further enhance the predictivity of this assay. 439 
An immortalised hepatic cell line (such as THLE2 or THLE3), which is capable of metabolic bio-440 
activation, would enhance the biological significance of further POP studies by HCA. 441 
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Although the concentrations investigated in this study were tested above the reported 442 
concentrations of POPs in Scandinavian human serum, exposure to POPs is individualistic in nature 443 
and certain groups of people may thus have higher levels of specific compounds in their blood. 444 
Elderly people often have higher concentrations of POPs present in their serum (Salihovic et al. 445 
2012) as POPs tend to bioaccumulate and their concentrations increase with age. Furthermore, 446 
people in countries who consume “traditional” foods such as whale blubber may have higher levels 447 
of POPs present in their serum (Van Oostdam et al. 2005; Weihe et al. 1996; Weihe et al. 2008). 448 
Finally, levels of certain compounds may be higher in specific groups of people due to occupational 449 
exposure. These differences emphasise that the present study is useful for investigating the 450 
mechanisms by which POP mixtures can exert their effects, and may, especially for any higher risk 451 
groups highlight possible health risks. 452 
 453 
5. Conclusions  454 
The present study is focused on developing an improved understanding of POP mixture induced 455 
toxicity. The combination of different markers allows stronger inferences to be made about the 456 
action of the POP mixtures on HepG2 cells. The Br and Cl mixtures were able to induce ROS 457 
generation but it did not lead to apoptosis. The PFC mixture induced the production of ROS and 458 
likely induced cell apoptosis accompanied by the dissipation of MMP. Comparison of the PFC + Br 459 
mixture to each independent mixture showed that for some concentrations MM and ROS induction 460 
were synergistic. These toxicological findings show that the POP mixtures can increase ROS induction 461 
and impact mitochondrial health, which could result in apoptosis. HCA has an advantage over 462 
conventional toxicity assays such as the MTT assay by simultaneously measuring multiple 463 
parameters. Consequently, HCA is more predictive because a wider spectrum of effects is assessed. 464 
Furthermore the HCA assay was able to detect early, reversible signs of cellular stress after exposure 465 
to the Cl mixture, which conventional assays would have missed. Further study on mixtures, relevant 466 
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to real life exposure, their toxicity and the mechanisms behind any toxic effects are important areas 467 
of research.  468 
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Tables: 743 
Table 1. The composition and concentrations of original stocks supplied by the Norwegian University of Life 744 
Sciences, Oslo. The estimated concentration of POPs in the Total, Cl, PFC + Cl and Br + Cl stock solutions are 745 
1,000,000  times the estimated concentrations in human serum, in comparison with the PFC, Br and PFC + Br 746 
stock solutions where the estimated concentration of POPs are 10,000,000 times the estimated concentrations 747 
in human serum. 748 
 749 
Compound Mixture Stock Concentration (mg/ml) 
Perfluorinated compounds (PFCs) Total PFC Br Cl PFC+Br PFC+Cl Br+Cl 
PFOA 4.523 45.225     45.225 4.523   
PFOS  29.425 294.250     294.250 29.425   
PFDA 0.495 4.950     4.950 0.495   
PFNA 0.800 8.000     8.000 0.800   
PFHxS  3.450 34.500     34.500 3.450   
PFUnDA  0.560 5.600     5.600 0.560   
Polybrominated diphenyl ethers (PBDEs)               
BDE-209  0.011   0.108   0.108   0.011 
BDE-47 0.009   0.086   0.086   0.009 
BDE-99 0.004   0.035   0.035   0.004 
BDE-100 0.002   0.022   0.022   0.002 
BDE-153 0.001   0.010   0.010   0.001 
BDE-154 0.002   0.018   0.018   0.002 
HBCD 0.025   0.246   0.246   0.025 
Polychlorinated biphenyls (PCBs)               
PCB 138 0.222     0.222   0.222 0.222 
PCB 153 0.362     0.362   0.362 0.362 
PCB 101 0.008     0.008   0.008 0.008 
PCB 180 0.194     0.194   0.194 0.194 
PCB 52  0.010     0.010   0.010 0.010 
PCB 28  0.013     0.013   0.013 0.013 
PCB 118 0.064     0.064   0.064 0.064 
Other organochlorines               
p,p'-DDE 0.502     0.502   0.502 0.502 
HCB 0.117     0.117   0.117 0.117 
α - chlordane 0.011     0.011   0.011 0.011 
oxy - chlordane 0.022     0.022   0.022 0.022 
trans-nonachlor 0.041     0.041   0.041 0.041 
α-HCH 0.006     0.006   0.006 0.006 
β-HCH 0.053     0.053   0.053 0.053 
γ-HCH (Lindane) 0.006     0.006   0.006 0.006 
Dieldrin 0.024     0.024   0.024 0.024 
 750 
Table 2. Summary results for all HCA parameters and the MTT assay for HepG2 cells after 2 h 751 
exposure to POP mixtures. The PFC, Br and PFC + Br mixtures were tested at concentrations 752 
equivalent to 500, 1000, 5000 and 10,000 times serum levels. The Cl mixture was tested at 753 
concentrations equivalent to 50, 100, 500 and 1000 times serum levels. Note: Total, Br + Cl and PFC 754 
27 
 
+ Cl mixture results are not shown as no significant effects were observed at any concentration. Grey 755 
indicates no significant effects were highlighted while cells with arrows indicate significant changes 756 
in that parameter. ↑ shows an increase in the parameter while ↓ shows a decrease. 757 
 758 
Cell Health 
 
Parameter 
PFC Mix Br Mix Cl Mix PFC + Br Mix 
50
0 
100
0 5000 
1000
0 
50
0 
100
0 
500
0 
1000
0 
5
0 
10
0 
50
0 
100
0 
50
0 
100
0 
500
0 
1000
0 
CN       ↓                         
NI                               ↑ 
NA                               ↓ 
MM           ↑                     
MMP     ↓ ↓                       ↓ 
ROS       ↑       ↑     ↑ ↑       ↑ 
MTT     ↓ ↓                       ↓ 
 759 
Table 3. Summary results for all HCA parameters and the MTT assay for HepG2 cells after 48 h 760 
exposure to POP mixtures. The PFC, Br and PFC + Br mixtures were tested at concentrations 761 
equivalent to 500, 1000, 5000 and 10,000 times serum levels. The Cl mixture was tested at 762 
concentrations equivalent to 50, 100, 500 and 1000 times serum levels. Note: Total, Br + Cl and PFC 763 
+ Cl mixture results are not shown as no significant effects were observed at any concentration. Grey 764 
indicates no significant effects were highlighted while cells with arrows indicate significant changes 765 
in that parameter. ↑ shows an increase in the parameter while ↓ shows a decrease. 766 
 767 
Cell 
Health  
Parameter 
PFC Mix Br Mix Cl Mix PFC + Br Mix 
500 
100
0 
500
0 
1000
0 
50
0 
100
0 
500
0 
1000
0 
5
0 
10
0 
50
0 
100
0 
50
0 
100
0 
500
0 
1000
0 
CN     ↓ ↓                     ↓ ↓ 
NI     ↑ ↑                     ↑ ↑ 
NA     ↑                       ↑ ↑ 
MM     ↑ ↑           ↑ ↑ ↑       ↑ 
MMP     ↓ ↓                     ↓ ↓ 
ROS       ↑       ↑       ↑       ↑ 
MTT     ↓ ↓                     ↓ ↓ 
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Figures: 770 
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 771 
Figure 1. Cell viability of HepG2 cells after exposure to three POP mixtures, PFC, Br and PFC + Br. Cells were 772 
exposed to concentrations of POPs (500, 1000, 5000 and 10000 times serum levels) for 2 h and 48 h and 773 
cytotoxicity measured by conventional MTT. Data is expressed as a percentage of untreated control for each 774 
parameter; mean ± SEM, n=3. p ≤ 0.05 (*), p ≤ 0.01 (**) and p ≤ 0.001 (***) represent significant cytotoxic 775 
effects. 776 
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Figure 2. Nuclear changes in HepG2 cells after exposure to POP mixtures, PFC, Br and PFC + Br. Cells were 780 
exposed to concentrations of POPs (500, 1000, 5000 and 10000 times serum levels) for 2 h and 48 h and 781 
cytotoxicity measured by multi-parameter HCA endpoints CN (A), NI (B) and NA (C). Data is expressed as a 782 
percentage of untreated control for each parameter; mean ± SEM, n=3. p ≤ 0.05 (*), p ≤ 0.01 (**) and p ≤ 0.001 783 
(***) represent significant cytotoxic effects. 784 
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 786 
Figure 3. Mitochondrial mass changes after exposure to four POP mixtures, Total, Cl, PFC + Cl and Br + Cl, in 787 
HepG2 cells. Cells were exposed to concentrations of POPs (50, 100, 500 and 1000 times serum levels) for 2 h 788 
and 48 h and cytotoxicity measured by multi-parameter HCA endpoint MM. Data is expressed as a percentage 789 
of untreated control for each parameter; mean ± SEM, n=3. p ≤ 0.05 (*), p ≤ 0.01 (**) and p ≤ 0.001 (***) 790 
represent significant cytotoxic effects. 791 
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 794 
Figure 4. Mitochondrial changes after exposure to three POP mixtures, PFC, Br and PFC + Br, in HepG2 cells. 795 
Cells were exposed to concentrations of POPs (500, 1000, 5000 and 10000 times serum levels) for 2 h and 48 h 796 
and cytotoxicity measured by multi-parameter HCA endpoints MM (A) and MMP (B). Data is expressed as a 797 
percentage of untreated control for each parameter; mean ± SEM, n=3. p ≤ 0.05 (*), p ≤ 0.01 (**) and p ≤ 0.001 798 
(***) represent significant cytotoxic effects. 799 
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Figure 5. ROS production in HepG2 cells after exposure to four POP mixtures, PFC, Br, PFC + Br and Cl. Cells 803 
were exposed to concentrations of POPs (500, 1000, 5000 and 10000 times serum levels (NOTE – Cl mixture 804 
was not tested at 5000 or 10000 times serum levels) for 2 h and 48 h  and cytotoxicity measured by multi-805 
parameter HCA endpoint ROS. Data is expressed as a percentage of untreated control for each parameter; 806 
mean ± SEM, n=3. p ≤ 0.05 (*), p ≤ 0.01 (**) and p ≤ 0.001 (***) represent significant cytotoxic effects. 807 
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 810 
 811 
Figure 6. HCA images for (A) negative control (DMSO), (B) positive control (100 µM menadione), (C) example of mix - PFC + Br (10000 times serum level) – 2 h exposure. 812 
Each image was acquired at 10 × objective magnification using Hoechst dye (blue; nuclear staining) and CellROX dye (red; ROS). Arrow indicates an area of increased red 813 
fluorescence due to increased ROS production. 814 
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